The present invention relates to the use of a nonimmunosuppressive cyclosporin A derivative for reducing mitochondrial dysfunction and the rate of apoptosis of muscle cells of patients diagnosed with Ullrich congenital muscular dystrophy or Bethlem myopathy.

 
Web www.patentalert.com

< METHODS FOR ENCAPSULATING PLASMIDS IN LIPID BILAYERS

> Use of VEGF and homologues to treat neuron disorders

> Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules

~ 00582